MorphoSys

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MorphoSys and other ETFs, options, and stocks.

About MOR

MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. 

CEO
Jean-Paul Kress
CEOJean-Paul Kress
Employees
564
Employees564
Headquarters
Planegg, Bayern (Bavaria)
HeadquartersPlanegg, Bayern (Bavaria)
Founded
1992
Founded1992
Employees
564
Employees564

MOR Key Statistics

Market cap
2.73B
Market cap2.73B
Price-Earnings ratio
-11.74
Price-Earnings ratio-11.74
Dividend yield
Dividend yield
Average volume
412.93K
Average volume412.93K
High today
$18.16
High today$18.16
Low today
$18.10
Low today$18.10
Open price
$18.15
Open price$18.15
Volume
274.03K
Volume274.03K
52 Week high
$18.31
52 Week high$18.31
52 Week low
$3.89
52 Week low$3.89

MOR News

TipRanks 1d
MorphoSys AG Reports Major Shareholding Changes - TipRanks.com - TipRanks

Morphosys (MOR) has released an update. MorphoSys AG has announced a significant change in their major shareholdings, with DWS Investment GmbH’s voting rights...

Yahoo Finance 7d
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Yahoo Finance

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S. antitrust clearance under the...

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Yahoo Finance

Analyst ratings

70%

of 10 ratings
Buy
30%
Hold
70%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.